Case Study on Injectable Packaging for Biosimilars

This case study outlines the collaboration between a large Indian biopharmaceuticals company and West Pharmaceutical Services to develop injectable packaging for a monoclonal antibody biosimilar intended for oncology treatment. The company faced challenges in ensuring high-quality standards during the early stages of development, necessitating reliable packaging solutions. They required stoppers that matched the quality and performance of existing innovator products while aiming for regulatory approval in both emerging and developed markets. The solution involved selecting NovaPure stoppers from West's Ready Pack containment solution, which provided ready-to-use components designed for biologics. The stoppers were produced with FluroTec barrier film to minimize contamination risks. The partnership facilitated a smooth transition from small-scale R&D to larger commercial volumes, ensuring compliance with regulatory standards. The company successfully launched its biosimilar in India and other markets, subsequently adopting a platform strategy for future biosimilars, further solidifying the effectiveness of West's packaging solutions.